Document is current
Any future updates will be listed below
-
Authors
Chéret, Jérémy
Bertolini, Marta
Ponce, Leslie
Lehmann, Janin
Tsai, Teresa
Alam, Majid
Hatt, Hanns
Paus, Ralf
-
Funding
Funding for this research was provided by:
This study was supported in part by a research grant from Giuliani Pharma S.p.A., Milano, to Monasterium Laboratory GmbH, Münster.
- License Information
-
More Information
Article History
Received: 4 September 2017
Accepted: 7 August 2018
First Online: 18 September 2018
Competing interests
: J.C., M.B., L.P., J.L. and M.A. are or were employees of Monasterium Laboratory GmbH, Münster, which was founded by R.P. R.P., also serves as consultant for Giuliani Pharma, which has filed a patent on the use of compounds and compositions targeting OR2AT4 for hair growth-promotion or inhibition in humans (wo2017198818 (a1)—compounds for promoting hair growth and/or inhibiting or delaying hair loss in humans, and compositions for such uses). The remaining authors declare no competing interests.
